Loading…
Ingevity Corporation is projected to rise to $82.40 by 2027, a +20% move from its current price of $68.93. NGVT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $67.59 | $68.96 | $70.37 | +0.05% |
| May 30 | $67.06 | $69.00 | $70.99 | +0.10% |
| May 31 | $66.66 | $69.03 | $71.48 | +0.14% |
| Jun 1 | $66.33 | $69.06 | $71.91 | +0.19% |
| Jun 2 | $66.05 | $69.10 | $72.28 | +0.24% |
| Jun 3 | $65.80 | $69.13 | $72.63 | +0.29% |
| Jun 4 | $65.57 | $69.16 | $72.95 | +0.34% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $65.57 | $69.16 | $72.95 | +0.34% |
| Week 2 | $64.35 | $69.40 | $74.84 | +0.68% |
| Week 3 | $63.48 | $69.63 | $76.37 | +1.02% |
| Week 4 | $62.79 | $69.87 | $77.73 | +1.36% |
| Week 5 | $62.22 | $70.10 | $78.98 | +1.70% |
| Week 6 | $61.72 | $70.34 | $80.16 | +2.04% |
| Week 7 | $61.28 | $70.57 | $81.28 | +2.39% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Ingevity Corporation, ticker NGVT, is a Basic Materials company that manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America.
It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications.
The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices.
It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Ingevity Corporation (NGVT) trades at $66.67 per share. It has a market cap of $2.32B and is ranked 1899 by market capitalization.
The multi-year forecast landscape shows a neutral near-term in 2026, with a gradual move toward bullish upside through 2027 to 2050. The 2027 average price is $79.24, rising to $118.00 by 2030, and reaching $572.11 by 2050, with corresponding ROIs of 18.9% in 2027, 77% in 2030, 329.5% in 2040, and 758.1% in 2050. The long-run path implies meaningful upside potential but remains contingent on market conditions and other factors; these figures are estimates, not guarantees.
A major floor 16.2% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
The nearest ceiling, 13.0% above — a clean break opens room to run.
A major ceiling 21.1% above — clearing it would confirm fresh momentum.
Key NGVT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NGVT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $67.09 | Buy | $67.82 | Buy |
| MA 10 | $67.72 | Buy | $68.46 | Buy |
| MA 20 | $71.34 | Sell | $70.09 | Sell |
| MA 50 | $71.81 | Sell | $70.87 | Sell |
| MA 100 | $70.09 | Sell | $68.57 | Buy |
| MA 200 | $62.60 | Buy | $63.20 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.23 | Neutral |
| Stoch RSI (14) | 61.63 | Neutral |
| CCI (20) | -44.30 | Neutral |
| Williams %R (14) | -63.15 | Info |
| MACD (12,26,9) | -0.46 | Sell |
| ROC (12) | -8.86 | Sell |
| Bollinger %B (20,2) | 0.35 | Neutral |
| Stochastic %K (14) | 36.85 | Neutral |
| TRIX (15) | -0.25 | Sell |
| Awesome (5,34) | -5.84 | Sell |
| Ultimate (7,14,28) | 47.96 | Neutral |
| Momentum (10) | -2.63 | Sell |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 67.65 | Buy |
| ADX (14) | 18.63 | Neutral |
| ATR (14) | 1.40 | Info |
30-day technical snapshot:
Sentiment: BULLISH. RSI(14): 40. SMA(50): $71.67. SMA(200): $62.42.
The 30-day range is $58.18 to $76.39, with a support level near $65.02 and a resistance near $77.87.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $60.09 | $68.93 | $91.07 | 0% | Neutral | |
| $67.01 | $82.40 | $106.28 | +20% | Neutral | |
| $70.65 | $88.59 | $117.43 | +29% | Bullish | |
| $82.95 | $105.71 | $143.23 | +53% | Bullish | |
| $96.39 | $124.60 | $171.99 | +81% | Bullish | |
| $108.71 | $142.37 | $199.76 | +107% | Bullish | |
| $121.64 | $161.22 | $229.58 | +134% | Bullish | |
| $124.78 | $167.25 | $241.40 | +143% | Bullish | |
| $129.06 | $174.84 | $255.50 | +154% | Bullish | |
| $137.81 | $188.60 | $278.83 | +174% | Bullish | |
| $215.36 | $308.46 | $478.95 | +348% | Bullish | |
| $400.48 | $619.01 | $1,033.60 | +798% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $60.09 | $68.93 | $81.14 | +0.00% |
| June 2026 | $61.53 | $71.85 | $85.59 | +4.24% |
| July 2026 | $61.30 | $72.02 | $86.66 | +0.24% |
| August 2026 | $61.46 | $72.57 | $88.00 | +0.76% |
| September 2026 | $62.90 | $74.56 | $90.98 | +2.74% |
| October 2026 | $62.71 | $74.60 | $91.56 | +0.06% |
| November 2026 | $61.14 | $72.97 | $90.01 | -2.19% |
| December 2026 | $61.37 | $73.48 | $91.07 | +0.69% |
Click any year to see its month-by-month NGVT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, NGVT is projected to trade between $60.09 and $91.07, averaging $68.93 — a potential gain of 0% from today's $68.93. Price action looks broadly range-bound.
Ingevity Corporation's 2027 outlook centres on $82.40, within a $67.01 to $106.28 range. That is up +20% on the projected 2026 average. That marks a +20% change versus current levels. A consolidation phase looks the most probable path here.
By 2028, NGVT could reach as high as $117.43, with a base case around $88.59 and support toward $70.65 — roughly +29% from $68.93. Momentum favours further upside here.
Expect NGVT to range from $82.95 to $143.23 through 2029. The $105.71 average target implies a +53% move from current prices. That is up +19% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The NGVT price prediction for 2030 points to an average of $124.60 (low $96.39, high $171.99) — a potential gain of +81% on today's $68.93. Momentum favours further upside here.
In 2031, NGVT is projected to trade between $108.71 and $199.76, averaging $142.37 — a potential gain of +107% from today's $68.93. That is up +14% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Ingevity Corporation's 2032 outlook centres on $161.22, within a $121.64 to $229.58 range. That is up +13% on the projected 2031 average. That marks a +134% change versus current levels. Momentum favours further upside here.
By 2033, NGVT could reach as high as $241.40, with a base case around $167.25 and support toward $124.78 — roughly +143% from $68.93. Buyers look set to stay in control over this stretch.
Expect NGVT to range from $129.06 to $255.50 through 2034. The $174.84 average target implies a +154% move from current prices. That is up +5% on the projected 2033 average. Momentum favours further upside here.
The NGVT price prediction for 2035 points to an average of $188.60 (low $137.81, high $278.83) — a potential gain of +174% on today's $68.93. Buyers look set to stay in control over this stretch.
In 2040, NGVT is projected to trade between $215.36 and $478.95, averaging $308.46 — a potential gain of +348% from today's $68.93. That is up +64% on the projected 2035 average. Momentum favours further upside here.
Ingevity Corporation's 2050 outlook centres on $619.01, within a $400.48 to $1,033.60 range. That is up +101% on the projected 2040 average. That marks a +798% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in NGVT today (≈ 14.507471 NGVT) could be worth
$8,980.21
+$7,980.21 (+798%) by 2050 · US Dollar
Based on the average projected NGVT price of $619.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NGVTwould be worth at today's price.
$1,000 invested in NGVT on May 27, 2025 (≈ 22.857143 NGVT) would be worth
$1,575.54
+$575.54 (+57.6%) today · 1.58× · US Dollar
Based on a NGVT entry price of $43.75 vs. today's $68.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $66.09 | $1,042.97 | +4.3% |
| 1 month ago | $76.32 | $903.17 | -9.7% |
| 3 months ago | $70.52 | $977.45 | -2.3% |
| 6 months ago | $52.23 | $1,319.74 | +32.0% |
| 1 year ago | $43.75 | $1,575.54 | +57.6% |
| All time (5.0y) ago | $85.5 | $806.2 | -19.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NGVT forecast.
Our base-case forecast reaches $140.00 around 2031.
Implied market cap at $140.00: $4.87B
Multi-year forecast highlights strong upside potential in the distant horizon. The 2030 average price is $118.00 with a 77% ROI, followed by a 2040 average of $286.38 with a 329.5% ROI, and a 2050 average of $572.11 with a 758.1% ROI. The 2026 projection is $66.67 (avg) with a 0% ROI, and 2027 shows $79.24 (avg) with an 18.9% ROI, continuing the bullish trajectory through 2050.
These are estimates, not guarantees, and reflect potential outcomes under varying conditions.
Tap a question to reveal the answer.
2030 avg $118.00; min $90.99; max $163.55; ROI 77%; sentiment BULLISH.
Forecasts show a neutral start in 2026 (avg $66.67, ROI 0) and bullish upside thereafter, with 2027 avg $79.24 (ROI 18.9%), 2030 avg $118.00 (ROI 77%), 2040 avg $286.38 (ROI 329.5%), and 2050 avg $572.11 (ROI 758.1%), all with sentiment BULLISH.
Yes. The 2029 forecast shows avg $100.90, min $78.95, max $137.22, ROI 51.3%, sentiment BULLISH.
Current price is $66.67.
2050 avg $572.11; min $367.04; max $962.37; ROI 758.1%; sentiment BULLISH.
Ingevity Corporation Community Discussion
0Share your Ingevity Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.